Related Experiment Video
Updated: Feb 13, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Beyond JNC 8: implications for evaluation and management of hypertension in underserved populations
Joseph Burns1, Dharam Persaud-Sharma1, Dollie Green1,2
1a Herbert Wertheim College of Medicine , Florida International University , Miami , FL , USA.
Insights
Hypertension affects 1 in 3 US adults, leading to significant mortality and costs. Guidelines vary, and current recommendations may not suit all racial groups due to differing responses to treatment.
Area of Science:
- Cardiology
- Public Health
- Health Disparities
Background:
- Hypertension affects nearly one-third of US adults, posing a major public health challenge with substantial economic burden.
- Existing hypertension management guidelines from organizations like ACC, ESC, and JNC (7, 8) exhibit considerable variation.
- Concerns exist regarding the universal applicability of these guidelines due to documented racial differences in pharmacotherapy response and clinical outcomes.
Purpose of the Study:
- To review the historical evolution of hypertension management guidelines.
- To examine the adjustments in blood pressure (BP) goals and pharmacotherapy strategies.
- To discuss socioeconomic factors influencing clinical risks in minority racial groups under JNC-8 guidelines.
Main Methods:
- Literature review of hypertension management guidelines.
- Analysis of historical trends in BP goal setting.
- Discussion of pharmacotherapy efficacy and adverse events across different populations.
- Exploration of socioeconomic determinants of health in hypertension management.
Main Results:
- Guidelines for hypertension management have evolved significantly over time, with varying BP targets.
- Evidence suggests differential responses to antihypertensive medications among racial groups.
- Socioeconomic factors exacerbate hypertension-related risks in certain minority populations, particularly concerning new BP targets.
Conclusions:
- Hypertension remains a critical US health issue requiring nuanced management strategies.
- Current guidelines may necessitate adjustments to account for racial and socioeconomic disparities.
- Further research is needed to ensure equitable and effective hypertension care for all populations.
Abstract:
In the United States, hypertension is a significant medical problem that affects nearly 1 in 3 adults, causes thousands of deaths annually, and costs the nation billions of dollars annually for medical management in terms of hospitalisations, lost wages, and pharmacotherapy. The management guidelines of hypertension have greatly varied between different healthcare organisations including the American College of Cardiology (ACC), the European Society of Cardiology (ESC) and the Joint National Committee (JNC-7, 8). One of the points of contention is the generalisability of the guidelines to all individuals despite empirical evidence suggesting racial sensitivities to pharmacotherapy and high clinical adversities with elevations in blood pressure (BP). This manuscript will aim to review a brief history of the guidelines, the adjustment of the BP goals with pharmacotherapy for the management of hypertension, and discuss several socioeconomic factors attributing to higher clinical risks for certain minority racial groups susceptible to the new BPs goals for management under the JNC-8.
Related Concept Videos
Hypertension V: Nursing Management
Conservation of Small Populations
What is Population Genetics?
Population Growth
What are Populations and Communities?
Hypertension I: Introduction

